Shanghai Dahua is committed to advancing global family planning efforts, particularly the FP2020 goals, which aim to reach an additional 120 million women with family planning methods by 2020.

With a strong belief in the importance of women’s empowerment, Shanghai Dahua is dedicated to expanding access to high-quality, affordable contraceptives, including their WHO-prequalified implant product, Levoplant.